📖
NRF2 signaling drives chemoresistance in NSCLC and glioblastoma.
de Souza I, Monteiro LKS, da Silva Teixeira AB, Guedes CB, Lima KA, de Souza Filho CHD, de Andrade IAM, Ramalho MCC, de Oliveira BS, Lazarini M, Rocha CRR

NRF2 signaling drives chemoresistance in NSCLC and glioblastoma.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Mol Cell Biochem.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title NRF2 signaling drives chemoresistance in NSCLC and glioblastoma.
Author / Organization de Souza I, Monteiro LKS, da Silva Teixeira AB, Guedes CB, Lima KA, de Souza Filho CHD, de Andrade IAM, Ramalho MCC, de Oliveira BS, Lazarini M, Rocha CRR
Subject & Discipline Mol Cell Biochem
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-66755
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »